fda semaglutide shortage resolved feb 21 2025 GLP-1 = Over FDA Declares Shortage of Novo

Regardless of age, menopausal status, and cyst size, EAOC exhibits lower R2 values and total iron levels compared to benign ovarian endometriosis cysts

A consultation with your medical provider can assist in determining your medical condition and overall health goals

Patients diagnosed with diastolic heart failure (HFpEF) account for approximately half of heart failure hospitalizations

TREM2 sustains microglial expansion during aging and response to demyelination

The study isnt yet peer-reviewed, but it appears to show retatrutide leaving other GLP-1s in the dust: The highest dose made patients lose an average of 28% of their body mass after 80 weeks, running nearly a full lap around the highest dose of Novo Nordisks Wegovy (~15% weight loss after 68 weeks)